Haemodialysis-associated hypoglycaemia and inter-day glycaemic variability assessed by continuous glucose monitoring system in patients with type 2 diabetes

被引：0

作者：

Popa, S. ^{[1
]}

Vaduva, C. ^{[2
]}

Mota, E. ^{[1
]}

Mota, M. ^{[1
]}

机构：

[1] Univ Med & Pharm, Craiova, Romania

[2] Clin Cty Emergency Hosp, Craiova, Romania

来源：

DIABETOLOGIA | 2013年 / 56卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1180

引用

页码：S474 / S474

页数：1

共 50 条

[11] Risk factors of severe hypoglycaemia and occurrence of silent hypoglycaemia in patients with type 1 diabetes assessed by continuous glucose monitoring [J].

Pedersen-Bjergaard, U ;

Hoi-Hansen, T ;

Pramming, S ;

Thorsteinsson, B .

DIABETOLOGIA, 2005, 48 :A293-A293

[12] SHORT-TERM GLUCOSE VARIABILITY CHANGE IN TYPE 2 DIABETES ASSESSED BY CONTINUOUS GLUCOSE MONITORING [J].

Morosanu, A. ;

Morosanu, M. .

DIABETES TECHNOLOGY & THERAPEUTICS, 2018, 20 :A70-A70

[13] The Durability of Basal Insulin Affects Day-to-Day Glycemic Variability Assessed by Continuous Glucose Monitoring in Type 2 Diabetes Patients: A Randomized Crossover Trial [J].

Iuchi, Hiroyuki ;

Sakamoto, Masaya ;

Matsutani, Daisuke ;

Suzuki, Hirofumi ;

Horiuchi, Ryuzo ;

Utsunomiya, Kazunori .

DIABETES TECHNOLOGY & THERAPEUTICS, 2017, 19 (08) :457-462

[14] Association of glycemic variability assessed by continuous glucose monitoring with subclinical diabetic polyneuropathy in type 2 diabetes patients [J].

Pan, Jiemin ;

Yan, Xinfeng ;

Li, Fengwen ;

Zhang, Yinan ;

Jiang, Lan ;

Wang, Congrong .

JOURNAL OF DIABETES INVESTIGATION, 2022, 13 (02) :328-335

[15] CLINICAL FACTORS ASSOCIATED WITH DAILY AND DAY-TO-DAY GLUCOSE VARIABILITY DETERMINED BY CONTINUOUS GLUCOSE MONITORING AND THE GLUCAGON STIMULATION TEST IN TYPE 2 DIABETES PATIENTS [J].

Ohara, M. ;

Tomoyasu, M. ;

Nagaike, H. ;

Goto, S. ;

Tanabe, Y. ;

Kushima, H. ;

Hiromura, M. ;

Yamamoto, T. ;

Hayashi, T. ;

Fukui, T. ;

Hirano, T. .

DIABETES TECHNOLOGY & THERAPEUTICS, 2018, 20 :A71-A71

[16] Fear of hypoglycaemia was not associated with glycaemic variability in patients with type 1 diabetes: the VARDIA study [J].

Hadjadj, S. ;

Gand, E. ;

Chaillous, L. ;

Dubois, S. ;

Bonnet, F. ;

Fradet, G. ;

Crespin, I. Delcourt ;

Kerlan, V. ;

Gouet, D. ;

Perlemoine, C. ;

Ducluzeau, P-H. ;

Pichelin, M. ;

Ragot, S. ;

Saulnier, P-J. ;

Cariou, B. .

DIABETOLOGIA, 2017, 60 :S336-S337

[17] Reducing glycaemic variability decreases time in hypoglycaemia independent of mean glucose: data from real-world continuous glucose monitoring in type 1 diabetes patients [J].

Bergenstal, R. ;

Hachmann-Nielsen, E. ;

Kaas, A. ;

Kvist, K. .

DIABETOLOGIA, 2018, 61 :S449-S450

[18] Exenatide Improves Glycemic Variability Assessed by Continuous Glucose Monitoring in Subjects with Type 2 Diabetes [J].

Irace, Concetta ;

Fiorentino, Raffaella ;

Carallo, Claudio ;

Soavelli, Faustina ;

Gnasso, Agostino .

DIABETES TECHNOLOGY & THERAPEUTICS, 2011, 13 (12) :1261-1263

[19] Glucose control and variability assessed by continuous glucose monitoring in patients with type 1 diabetes and diabetic kidney disease [J].

Fedulovs, Aleksejs ;

Janevica, Jana ;

Kruzmane, Lelde ;

Sokolovska, Jelizaveta .

BIOMEDICAL REPORTS, 2025, 22 (02)

[20] Glycaemic variability using continuous glucose monitoring and endothelial function in the metabolic syndrome and in Type 2 diabetes [J].

Buscemi, S. ;

Re, A. ;

Batsis, J. A. ;

Arnone, M. ;

Mattina, A. ;

Cerasola, G. ;

Verga, S. .

DIABETIC MEDICINE, 2010, 27 (08) :872-878

← 1 2 3 4 5 →